Sanofi (SNY) stock analysis
In our weekly check, Sanofi is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3.
About Sanofi
Sanofi is a Healthcare company (Drug Manufacturers - General) based in France, listed on NASDAQ as SNY.
What our checks show for SNY
Red flags
- The net margin fell by 7.7 points over 5 years, to 8.2%: the company keeps less of each sale as profit.
- The dividend takes 137% of profit: little cushion if profit falls.
- Recovering from its deepest fall took about 3.8 years.
Warning signs
- Analysts expect only about 1.9% a year of growth in revenue.
- Earnings per share fell 43% a year over the last 3 years.
- Net profit fell 20.7% a year over the last 3 years.
- The net margin is only 8.2%: little room if costs rise.
- The stock has fallen as much as 49% from a peak. Would you have held through that?
Strengths
- Net debt is only 0.9x a year of EBITDA: the balance sheet has room.
- Operating profit covers interest 14.2 times over.
- The gross margin is 73.7% and has risen by 5 points: pricing power is holding.
- Operating cash flow is 2.9x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 152% a year over the next years.
- Analysts expect the net margin to improve by 13.5 points from today's 8.2%.
Next earnings report: 2027-02-04
Similar companies
BMY · GSK · PFE · NVO · GILD · AMGN
Questions
What grade does Sanofi (SNY) have?
In our weekly check, Sanofi is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of SNY stock?
This week's biggest flags for Sanofi: Margins falling, Dividend stretched, Slow recovery after falls. In total 8 of 25 checks show a warning or a red flag.
What does Sanofi do?
Sanofi is a Healthcare company (Drug Manufacturers - General) based in France, listed on NASDAQ as SNY.
When does Sanofi report earnings next?
The next earnings report is expected on 2027-02-04. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis